Cell And Gene Articles, App Notes, Case Studies, & White Papers

1. A Scalable Manufacturing Platform For The Purification Of Stem Cell Derived Exosomes 5/16/2025

   EV production scale increases require paired robust, scalable, and cost-effective downstream processes. Process parameters can be tailored for therapeutic exosome programs and allow for maximum exosome recovery.

2. Monitoring Of A pH Optimization Approach For CHO Cell Cultivation 6/10/2026

   Cloud-based monitoring and analytics help centralize data, gain real-time insight, and improve decision-making. Enhanced visibility and collaboration enable faster optimization and consistency across development and manufacturing.

3. Unlock 14% Reduction In AAV Gene Therapy Cost Of Goods 3/25/2026

   Comparing plasmid DNA to enzymatically produced DNA shows how enzymatic methods cut manufacturing costs, speed production, and boost efficiency for large‑scale AAV gene therapy.

4. Reducing Plastic Waste Using Syringeless Filters 2/25/2026

   A streamlined approach to HPLC sample preparation can cut plastic waste by up to 79%. Find out how reducing consumables simplifies workflows and supports more sustainable, efficient lab operations.

5. Key Selection Criteria For Cell & Gene Therapy CDMOs 3/4/2026

   Choosing the right CDMO requires early internal assessment plus strong technical capability, agility, advocacy, clear communication, and long‑term alignment to meet evolving cell and gene therapy needs.

6. Modern Lentiviral Platforms For Scalable Cell Therapy 1/20/2026

   A new platform approach streamlines lentiviral vector design and manufacturing, boosting yield, lowering costs, and accelerating access to gene‑modified cell therapies worldwide.

7. Sensitive Viral Safety Testing For Adventitious Virus Detection 4/20/2026

   Discover a modern approach to adventitious virus detection that shows how targeted sequencing can achieve sensitive, comprehensive viral safety testing aligned with ICH MAP, RAP, and HAP expectations.

8. Accelerate LNP Manufacturing With Automated Process Development 2/5/2026

   Manual LNP formulation introduces process variability that threatens particle quality and yield. As programs scale toward clinical production, maintaining strict control over CQAs becomes essential.

9. Fluorescent Bacterial Colony Selection 3/10/2025

   Fluorescent reporter genes simplify screening bacterial transformants. Discover a system that automates colony picking to enhance efficiency and precision with fluorescence imaging.

10. Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere 4/27/2026

    Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.